
A Joint Venture of Quintiles and Thermo Fisher Scientific
CENDUIT NEWS
January 28, 2010 - Cenduit and invivodata, inc. Align to Integrate Clinical IRT and ePRO SolutionsDecember 9, 2009 - Cenduit Selects SAP BusinessObjects to Revolutionize Clinical Trial Reporting & Analytics
May 26, 2009 - Cenduit Announces New Vice President, Global Sales and Marketing
April 23, 2008 - Executives Join Cenduit’s Team

SAP BusinessObjects
Cenduit and SAP BusinessObjects have formally aligned to revolutionize Clinical Trial Reporting & Analytics. This unique partnership with SAP BusinessObjects facilitates enhanced custom reporting and analytics capabilities within Cenduit’s Interactive Response Technology solutions (IRT). Cenduit’s IRT solution is instrumental in collecting, analyzing, and managing clinical trial data.
In a complex and crowded industry, Cenduit has successfully differentiated itself by taking ownership of clients‘ customized IRT solution to help define and ensure clinical study success. Cenduit’s clients, Pharmaceutical, Clinical Research, and Biotechnology organizations, rely on IRT solutions to effectively manage their clinical studies. With the power of SAP® BusinessObjects™ Enterprise, Cenduit takes the business efficiencies of their proven IRT solution to the next level.
Cenduit’s unique customized approach offers a dramatic competitive distinction by tailoring each solution to client-specific business requirements. Real-time information on patient recruitment and drug supply management will enable our project managers to proactively advise clients and partners on business decisions to improve study productivity and dramatically reduce clinical trial costs. Business intelligence gleaned from trends in programs over time will help clinical trial personnel devise meaningful strategies for running cost-efficient clinical trials.
Together, Cenduit and SAP BusinessObjects, provide best-in-class clinical trial solutions that focus on transforming data-driven decision-making throughout the drug supply chain management and drug development process to achieve substantial study efficiencies and cost savings.
